OncoCyte (OCX) Announces Peer-Reviewed Publication of Data Assessing Use of DetermaIO to Identify Patients Likely to Benefit from Immunotherapy Across Multiple Tumor Types
Go back to OncoCyte (OCX) Announces Peer-Reviewed Publication of Data Assessing Use of DetermaIO to Identify Patients Likely to Benefit from Immunotherapy Across Multiple Tumor Types| (NASDAQ: OCX) | Delayed: 2.44 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.44 | 52 Week High | $10.24 | |||
| Open | $2.44 | 52 Week Low | $2.45 | |||
| Day High | $2.44 | P/E | N/A | |||
| Day Low | $2.44 | EPS | $-0.46 | |||
| Volume | 3 | |||||
